Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$4.0 - $5.82 $16,776 - $24,409
-4,194 Reduced 16.7%
20,926 $90,000
Q2 2023

Aug 14, 2023

BUY
$4.19 - $6.16 $105,252 - $154,739
25,120 New
25,120 $138,000
Q2 2022

Aug 15, 2022

BUY
$3.28 - $6.42 $5,772 - $11,299
1,760 Added 13.42%
14,870 $54,000
Q1 2022

May 16, 2022

BUY
$5.16 - $7.14 $67,647 - $93,605
13,110 New
13,110 $81,000
Q1 2020

May 13, 2020

SELL
$1.42 - $3.29 $36,868 - $85,421
-25,964 Closed
0 $0
Q4 2019

Feb 18, 2020

SELL
$2.45 - $3.25 $90,779 - $120,422
-37,053 Reduced 58.8%
25,964 $79,000
Q3 2019

Nov 14, 2019

BUY
$1.59 - $3.47 $18,905 - $41,258
11,890 Added 23.26%
63,017 $194,000
Q2 2019

Aug 14, 2019

SELL
$1.93 - $4.59 $45,426 - $108,034
-23,537 Reduced 31.52%
51,127 $102,000
Q1 2019

May 01, 2019

SELL
$2.77 - $4.38 $826,615 - $1.31 Million
-298,417 Reduced 79.99%
74,664 $322,000
Q4 2018

Feb 01, 2019

SELL
$3.03 - $5.0 $152,512 - $251,670
-50,334 Reduced 11.89%
373,081 $1.19 Million
Q3 2018

Nov 14, 2018

BUY
$5.0 - $6.65 $650,290 - $864,885
130,058 Added 44.33%
423,415 $2.22 Million
Q2 2018

Aug 02, 2018

BUY
$4.2 - $5.95 $132,627 - $187,889
31,578 Added 12.06%
293,357 $1.57 Million
Q1 2018

May 03, 2018

BUY
$3.3 - $5.15 $245,378 - $382,938
74,357 Added 39.67%
261,779 $1.31 Million
Q4 2017

Feb 01, 2018

BUY
$3.08 - $3.8 $118,050 - $145,646
38,328 Added 25.71%
187,422 $618,000
Q3 2017

Nov 17, 2017

BUY
$2.7 - $3.75 $402,553 - $559,102
149,094
149,094 $559,000

Others Institutions Holding HBIO

About HARVARD BIOSCIENCE INC


  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $89.1M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Algert Global LLC Portfolio

Follow Algert Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.